- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01865708
Pilot Study of the Safety of a Daily Ethanol Lock for Urinary Catheters in Critically Ill Children
Hypothesis 1: Blood alcohol concentration will be <25 mg/100ml (equivalent to a blood alcohol concentration of <0.025%) after a 1 hour urinary catheter ethanol lock.
Hypothesis 2: Daily urinary catheter ethanol locks will not result in increased hematuria or increased urinary white cells.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study involves a confirmatory/refuting approach to the above stated hypothesis. The investigators will test this hypothesis by addressing the following aims/objectives:
Specific Aim 1:
Quantify blood alcohol levels after a 1 hour 74% ethanol lock in urinary catheters utilized in the Pediatric Intensive Care Unit.
Specific Aim 2:
Compare cellular components in urinalyses after the introduction of the ethanol locks.
Potential study subjects will be recruited from the Children's Healthcare of Atlanta - Egleston Pediatric Intensive Care Unit. Children that are anticipated to have an indwelling urinary catheter for >48 hours will be included. For this pilot study, the investigators will enroll 10 patients. Subject ages will range from 6 months to 17 years. Children who are on a service other than Critical Care Medicine will have clearance from the primary team prior to approaching for enrollment. The consent process will take place prior to or during the initial 24 hours of urinary catheter placement.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30329
- Children's Helathcare of Atlanta at Egleston
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 6 months - 17 years
- Urinary catheter placed at Children's Healthcare of Atlanta
- Anticipated urinary catheter need for > 48 hours
- Parent or legal guardian (or patient when applicable) consent for enrollment.
Exclusion Criteria:
- 18 yo or older.
- Urosepsis at time of study enrollment
- Known bladder or genitourinary abnormalities
- Chronic bladder drainage regimen
- Urologic surgeries (as part of the current admission)
- Medical urgency preventing timely administration of the consenting process, or any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating.
- Anuria or oliguria (<0.5 cc/kg/hr averaged over the previous 12 hours)
- Other technical considerations that would prevent the timely acquisition of sufficient samples such as (but not limited to) absence of a study team member.
- Parent or legal guardian (or patient when applicable) refuses to sign informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Ethanol lock
Ethanol lock, utilizing 74% ethanol, will begin within 24 hours of urinary catheter placement.
The lock will be done every 24 hours for 1 hour.
The volume that will be instilled depends upon the fill volume of the catheter, which is imprinted by the manufacturer on each catheter.
Once the alcohol is in the catheter, the proximal end of the catheter will be clamped for 1 hour.
After the 1 hour dwell time, the clamp will be removed and the alcohol in the lumen of the catheter will be flushed out by the patient's own urine output.
|
Ethanol lock, utilizing 74% ethanol, will begin within 24 hours of urinary catheter placement.
The lock will be done every 24 hours for 1 hour.
The volume that will be instilled depends upon the fill volume of the catheter, which is imprinted by the manufacturer on each catheter.
Once the alcohol is in the catheter, the proximal end of the catheter will be clamped for 1 hour.
After the 1 hour dwell time, the clamp will be removed and the alcohol in the lumen of the catheter will be flushed out by the patient's own urine output.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Alcohol Level
Time Frame: up to 3 days
|
An ethanol lock, utilizing 74% ethanol, will begin within 24 hours of catheter placement.
The lock will be done every 24 hours for 1 hour.
Blood alcohol levels will be obtained every day, approximately 1 hour after ethanol lock release, for 3 days: at baseline, 1 day post catheter placement, 2 days post catheter placement, and 3 days post catheter placement.
Number of participants with Blood Alcohol Levels exceeding 10 mg/100 ml on any study day was analyzed.
|
up to 3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urine Analysis
Time Frame: Data shown is the mean increase in red blood cells per high powered field after ethanol instillation averaged across all post-EL days and all patients compared to the mean baseline red blood cells per high powered field in urinalysis prior to any EL.
|
An ethanol lock, utilizing 74% ethanol, will begin within 24 hours of catheter placement. The lock will be done every 24 hours for 1 hour, for a total of 3 days. A baseline urinalysis will be obtained prior to the first instillation of ethanol, looking for hematuria. A urinalysis will be obtained approximately 1 hour after the lock is released. Data shown is the mean increase in red blood cells per high powered field after ethanol instillation averaged across all post-ethanol lock days and all patients compared to the mean baseline red blood cells per high powered field in urinalysis prior to any ethanol lock. |
Data shown is the mean increase in red blood cells per high powered field after ethanol instillation averaged across all post-EL days and all patients compared to the mean baseline red blood cells per high powered field in urinalysis prior to any EL.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jana A Stockwell, MD, Children's Healthcare of Atlanta
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ethanol Lock, Safety
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complication of Urinary Catheter
-
David Guadarrama-OrtegaTerminatedComplication of Urinary CatheterSpain
-
University Hospital, GrenobleCompletedComplication of CatheterFrance
-
Tehran University of Medical SciencesCompletedMechanical Complication of Peritoneal Dialysis CatheterIran, Islamic Republic of
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedComplication of CatheterUnited States
-
Boston Children's HospitalCompletedCatheter Related Complication | Dislodged CatheterUnited States
-
Consorci Sanitari de TerrassaRecruitingCatheter Related ComplicationSpain
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingCatheter Related ComplicationSpain
-
Ankara Diskapi Training and Research HospitalCompletedCatheter Related ComplicationTurkey
-
University of Alabama at BirminghamCompletedCatheter Related ComplicationUnited States
-
University of Turin, ItalyPall CorporationRecruitingCatheter Complications | Newborn ComplicationItaly
Clinical Trials on Ethanol Lock
-
IRCCS Policlinico S. MatteoUnknown
-
University of NebraskaWithdrawnShort Bowel Syndrome | Blood Stream InfectionsUnited States
-
Children's Hospital of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedLymphoma | Leukemia | Solid Tumors | Blood DisordersUnited States
-
Stanford UniversityTerminatedCatheter-Related InfectionsUnited States
-
Instituto Materno Infantil Prof. Fernando FigueiraBellisa Caldas Lopes; Thuanne Beatriz Silva Tenório; Rodrigo Melo Gallindo; Paulo... and other collaboratorsCompletedPediatric | Central Line-associated Bloodstream Infection (CLABSI) | Infection, Catheter-RelatedBrazil
-
East Carolina UniversityTerminatedSafety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature NeonatesSepsis | Bacteremia | Infection Associated With CatheterUnited States
-
Mayo ClinicTerminatedCatheter-related Bloodstream Infection (CRBSI) Nos | Bloodstream Infection Due to Central Venous Catheter | Bloodstream Infection Due to Hickman CatheterUnited States
-
Boston Children's HospitalWithdrawnShort Bowel Syndrome | Catheter Related InfectionsUnited States
-
University of PittsburghCompleted